XML 35 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2019     26,682,720        
Beginning balance at Dec. 31, 2019 $ 135,409 $ (461) $ 25 $ 395,695 $ (260,393) $ (461) $ 82
Increase (Decrease) in Stockholders' and Temporary Equity [Roll Forward]              
Issuance of common stock in connection with employee equity incentive plans, net (in shares)     1,079,488        
Issuance of common stock in connection with employee equity incentive plans, net 20,244     20,244      
Issuance of common stock in connection with follow-on public offering, net of issuance costs (in shares)     1,257,142        
Issuance of common stock in connection with follow-on public offering, net of issuance costs 206,025   $ 2 206,023      
Tax withholding upon vesting of restricted stock awards (10,009)     (10,009)      
Stock-based compensation 34,305     34,305      
Net loss (43,830)       (43,830)    
Net change in unrealized loss on short-term investments (71)           (71)
Ending balance (in shares) at Dec. 31, 2020     29,019,350        
Ending balance at Dec. 31, 2020 341,612   $ 27 646,258 (304,684)   11
Increase (Decrease) in Stockholders' and Temporary Equity [Roll Forward]              
Issuance of common stock in connection with employee equity incentive plans, net (in shares)     474,376        
Issuance of common stock in connection with employee equity incentive plans, net 8,943     8,943      
Tax withholding upon vesting of restricted stock awards (25,853)     (25,853)      
Stock-based compensation 56,246     56,246      
Net loss (101,361)       (101,361)    
Net change in unrealized loss on short-term investments $ (72)           (72)
Ending balance (in shares) at Dec. 31, 2021 29,493,726   29,493,726        
Ending balance at Dec. 31, 2021 $ 279,515   $ 27 685,594 (406,045)   (61)
Increase (Decrease) in Stockholders' and Temporary Equity [Roll Forward]              
Issuance of common stock in connection with employee equity incentive plans, net (in shares)     699,375        
Issuance of common stock in connection with employee equity incentive plans, net 13,183   $ 1 13,182      
Stock-based compensation 63,604     63,604      
Net loss (116,155)       (116,155)    
Net change in unrealized loss on short-term investments $ (335)           (335)
Ending balance (in shares) at Dec. 31, 2022 30,193,101   30,193,101        
Ending balance at Dec. 31, 2022 $ 239,812   $ 28 $ 762,380 $ (522,200)   $ (396)